FDA Clearance Tracker · P990040-S009
TRUFILL N-BUTYL CYANOACRYLATE (N-BCA) LIQUID EMBOLIC SYSTEM
Last checked: Nov 20, 2026Latest source record: Feb 25, 2010 (this decision)Source: openFDAMethods & limitations
Decided
Feb 25, 2010
Approved
Time to decision
178 days
Received Aug 31, 2009. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P990040-S009
- Device name
- TRUFILL N-BUTYL CYANOACRYLATE (N-BCA) LIQUID EMBOLIC SYSTEM
- Applicant
- Cerenovus, Inc.
- Applicant location
- Miami, FL
- Received
- Aug 31, 2009
- Decided
- Feb 25, 2010
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P990040
Device type
- Device class
- Class III
- Specialty
- Neurology & Neurosurgery
FDA's approval statement
As written in FDA's record.
APPROVAL FOR MANUFACTURING SITES LOCATED AT CODMAN & SHURTLEFF, INC. IN RAYNHAM, MASSACHUSETTS AND BRIDGEWATER, MASSACHUSETTS.
Source documents
Other decisions for Cerenovus, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262419 · Decided Aug 14, 2026 · 30 days after receipt
Device type: Device, Neurovascular Embolization (HCG) · Neurology & Neurosurgery
K262398 · Decided Aug 13, 2026 · 30 days after receipt
Device type: Catheter, Thrombus Retriever (NRY) · Cardiology
- TRUFILL n-BCA Liquid Embolic System (LES), TRUFILL n-BCA Liquid Embolic System Procedural SetPMA supplement
P990040-S034 · Decided Dec 16, 2025 · 316 days after receipt · Panel Track
Device type: Neurovascular Liquid Embolic Agent (SGU) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.